These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1867125)

  • 1. A clinical and neurophysiological trial on nootropic drugs in patients with mental decline.
    Gallai V; Mazzotta G; Del Gatto F; Montesi S; Mazzetti A; Dominici P; Della Monica A
    Acta Neurol (Napoli); 1991 Feb; 13(1):1-12. PubMed ID: 1867125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparative study of the nootropic properties of piracetam and oxiracetam].
    Krylova IN; Antonova LV; Kamenskiĭ AA; Iasnetsov VV
    Farmakol Toksikol; 1991; 54(1):14-6. PubMed ID: 1860490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encephalotropic and psychotropic effects of intravenous buflomedil in the elderly: double-blind, placebo-controlled pharmaco-EEG and psychometric studies.
    Saletu B; Grünberger J; Linzmayer L; Stöhr H
    Int J Clin Pharmacol Res; 1984; 4(2):95-107. PubMed ID: 6469443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of oxiracetam therapy in the treatment of cognitive deficiencies secondary to primary degenerative dementia.
    Rozzini R; Zanetti O; Bianchetti A
    Acta Neurol (Napoli); 1992 Apr; 14(2):117-26. PubMed ID: 1414555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of cognitive impairment secondary to degenerative dementia. Effectiveness of oxiracetam therapy.
    Rozzini R; Zanetti O; Bianchetti A
    Acta Neurol (Napoli); 1993 Feb; 15(1):44-52. PubMed ID: 8456595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can the pattern of neuropsychological improvement obtained with cholinergic drugs be used to infer a cholinergic mechanism in other nootropic drugs?
    Gainotti G; Nocentini U; Sena E
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13 Suppl():S47-59. PubMed ID: 2694229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CNS pharmacology and clinical therapeutic effects of oxiracetam.
    Itil TM; Menon GN; Songar A; Itil KZ
    Clin Neuropharmacol; 1986; 9 Suppl 3():S70-2. PubMed ID: 3594458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia].
    Tariska P; Paksy A
    Orv Hetil; 2000 May; 141(22):1189-93. PubMed ID: 10853348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive improvement in clinical trials with nootropic drugs: when can it be expected and how to clarify its meaning.
    Gainotti G; Benedetti N; Caltagirone C; Nocentini U
    Clin Neuropharmacol; 1986; 9 Suppl 3():S65-9. PubMed ID: 3297320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative influence of nootropic preparations on the emetic effect of morphine].
    Naumova VI; Krylova IN; Drozd IuV; Polev PV; Bashnin IuI
    Biull Eksp Biol Med; 1989 Jun; 107(6):711-3. PubMed ID: 2790169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sulpiride in psychiatric treatment. Clinical and psychometric study in 58 patients].
    Robert G; Mercier J
    Sem Hop; 1970 Jun; 46(29):Suppl:124-32. PubMed ID: 4316823
    [No Abstract]   [Full Text] [Related]  

  • 12. Selegiline versus oxiracetam in patients with Alzheimer-type dementia.
    Falsaperla A; Monici Preti PA; Oliani C
    Clin Ther; 1990; 12(5):376-84. PubMed ID: 2125242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-acetylcarnitine treatment of mental decline in the elderly.
    Salvioli G; Neri M
    Drugs Exp Clin Res; 1994; 20(4):169-76. PubMed ID: 7813389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial of piracetam in intellectually impaired patients with Parkinson's disease.
    Sano M; Stern Y; Marder K; Mayeux R
    Mov Disord; 1990; 5(3):230-4. PubMed ID: 2388639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nootropic effect of BR-16A (Mentat), a psychotropic herbal formulation, on cognitive deficits induced by prenatal undernutrition, postnatal environmental impoverishment and hypoxia in rats.
    Bhattacharya SK
    Indian J Exp Biol; 1994 Jan; 32(1):31-6. PubMed ID: 8045602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of oxiracetam in patients with organic brain syndrome: a neuropsychological study.
    Moglia A; Sinforiani E; Zandrini C; Gualtieri S; Corsico R; Arrigo A
    Clin Neuropharmacol; 1986; 9 Suppl 3():S73-8. PubMed ID: 3594459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Participation of dihydropyridine-sensitive calcium channels in psychotropic effects of nootropic drugs].
    Bobkov IuG; Polev PV; Machula AI; Val'dman EA; Soldatov NM; Dudkin SM
    Biull Eksp Biol Med; 1990 Oct; 110(10):386-9. PubMed ID: 2177669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oxiracetam on learning and memory in animals: comparison with piracetam.
    Mondadori C; Classen W; Borkowski J; Ducret T; Buerki H; Schadé A
    Clin Neuropharmacol; 1986; 9 Suppl 3():S27-38. PubMed ID: 3594453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacologic correction of learning and memory disorders induced by exposure to high-frequency electromagnetic radiation].
    Krylov IN; Iasnetsov VV; Dukhanin AS; Pal'tsev IuP
    Biull Eksp Biol Med; 1993 Mar; 115(3):260-2. PubMed ID: 8054613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind placebo-controlled, neuropsychological and neurophysiological investigations with oxiracetam (CGP 21690E) in memory-impaired patients with epilepsy.
    Aldenkamp AP; van Wieringen A; Alpherts WC; van Emde Boas W; Haverkort HA; de Vries J; Meinardi H
    Neuropsychobiology; 1990-1991; 24(2):90-101. PubMed ID: 2134116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.